Could cause temporary or reversible harm; serious harm is unlikely.
Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
| Brand name | IBUPROFEN |
| Generic name | IBUPROFEN |
| Active ingredient(s) | IBUPROFEN |
| Distributed by / for | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India |
| NDC | 51672-5321-8 |
| Full product label | Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8. |
| Recalling firm | STRIDES PHARMA INC |
| Distribution | U.S.A. Nationwide |
| Quantity | 89592 bottles |
| Recall initiated | 2026-03-02 |
| Report date | 2026-03-25 |
| Recall completed | — |
| Recall number | D-0390-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bridgewater NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗